Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Sep 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Government to nurture AI-specializing medical scientists

Jan 11
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pfizer and PostEra collab in $250M AI lab deal

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Nov 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Google’s New Company Will Discover Medicines Via Artificial Intelligence & Save Lives

Nov 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Breakthrough science and the future of venture capital

Nov 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Software Market Set to Reach New Heights Next Year

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Jan 7
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Alphabet's VC Arm adds Senior Healthcare Partner

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner: 75% of VCs will use AI to make investment decisions by 2025

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X